-
1
-
-
78149373656
-
Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence
-
29-7954-8-29
-
Boyle J.P., Thompson T.J., Gregg E.W., Barker L.E., & Williamson D.F. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health. Metr. 8, 29-7954-8-29 (2010).
-
(2010)
Popul. Health. Metr.
, vol.8
-
-
Boyle, J.P.1
Thompson, T.J.2
Gregg, E.W.3
Barker, L.E.4
Williamson, D.F.5
-
2
-
-
1542618210
-
Hypoglycemia as a barrier to glycemic control
-
Davis S., & Alonso M.D. Hypoglycemia as a barrier to glycemic control. J. Diabetes Complications 18, 60-68 (2004).
-
(2004)
J. Diabetes Complications
, vol.18
, pp. 60-68
-
-
Davis, S.1
Alonso, M.D.2
-
3
-
-
84896039279
-
Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
-
Anderson M., Powell J., Campbell K.M., & Taylor J.R. Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia. Diabetes Metab. Syndr. Obes. 7, 85-94 (2014).
-
(2014)
Diabetes Metab. Syndr. Obes.
, vol.7
, pp. 85-94
-
-
Anderson, M.1
Powell, J.2
Campbell, K.M.3
Taylor, J.R.4
-
4
-
-
0034912477
-
Hypoglycemia in patients with type 2 diabetes mellitus
-
Miller C.D., et al. Hypoglycemia in patients with type 2 diabetes mellitus. Arch. Intern. Med. 161, 1653-1659 (2001).
-
(2001)
Arch. Intern. Med.
, vol.161
, pp. 1653-1659
-
-
Miller, C.D.1
-
5
-
-
84879643475
-
Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus
-
Yaffe K., et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern. Med. 173, 1300-1306 (2013).
-
(2013)
JAMA Intern. Med.
, vol.173
, pp. 1300-1306
-
-
Yaffe, K.1
-
7
-
-
84962964135
-
-
US Department of Health and Human Services Office of Disease Prevention and Health Promotion. 3 November Asp#action-plan. (2014). Accessed
-
US Department of Health and Human Services Office of Disease Prevention and Health Promotion. National action plan for adverse drug event prevention. http://www.health.gov/hcq/ade. asp#action-plan. 2014). Accessed 3 November 2015.
-
(2015)
National Action Plan for Adverse Drug Event Prevention
-
-
-
8
-
-
84930465070
-
Standards of medical care in diabetes-2015: Summary of revisions
-
suppl.
-
Standards of medical care in diabetes-2015: summary of revisions Diabetes Care 38 (suppl.), S4-S003 (2015).
-
(2015)
Diabetes Care
, vol.38
, pp. S4-S13
-
-
-
10
-
-
0024515411
-
Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents
-
Jennings A.M., Wilson R.M., & Ward J.D. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 12, 203-208 (1989).
-
(1989)
Diabetes Care
, vol.12
, pp. 203-208
-
-
Jennings, A.M.1
Wilson, R.M.2
Ward, J.D.3
-
11
-
-
0024586640
-
Drug-induced hypoglycemia A review of 1418 cases
-
Seltzer H.S. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol. Metab. Clin. North Am. 18, 163-183 (1989).
-
(1989)
Endocrinol. Metab. Clin. North Am.
, vol.18
, pp. 163-183
-
-
Seltzer, H.S.1
-
13
-
-
70349989948
-
Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide
-
Zharikova O.L., et al. Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochem. Pharmacol. 78, 1483-1490 (2009).
-
(2009)
Biochem. Pharmacol.
, vol.78
, pp. 1483-1490
-
-
Zharikova, O.L.1
-
14
-
-
76949099719
-
The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
-
Tan B., Zhang Y.F., Chen X.Y., Zhao X.H., Li G.X., & Zhong D.F. The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects. Eur. J. Clin. Pharmacol. 66, 145-151 (2010).
-
(2010)
Eur. J. Clin. Pharmacol.
, vol.66
, pp. 145-151
-
-
Tan, B.1
Zhang, Y.F.2
Chen, X.Y.3
Zhao, X.H.4
Li, G.X.5
Zhong, D.F.6
-
15
-
-
0035208395
-
Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride
-
Niemi M., Neuvonen P.J., & Kivisto K.T. Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride. Clin. Pharmacol. Ther. 70, 439-445 (2001).
-
(2001)
Clin. Pharmacol. Ther.
, vol.70
, pp. 439-445
-
-
Niemi, M.1
Neuvonen, P.J.2
Kivisto, K.T.3
-
16
-
-
36549038966
-
PPAR agonists: Multimodal drugs for the treatment of type-2 diabetes
-
Gross B., & Staels B. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 21, 687-710 (2007).
-
(2007)
Best Pract. Res. Clin. Endocrinol. Metab.
, vol.21
, pp. 687-710
-
-
Gross, B.1
Staels, B.2
-
17
-
-
78651085122
-
Do statins beneficially or adversely affect glucose homeostasis?
-
Kostapanos M.S., Liamis G.L., Milionis H.J., & Elisaf M.S. Do statins beneficially or adversely affect glucose homeostasis?. Curr. Vasc. Pharmacol. 8, 612-631 (2010).
-
(2010)
Curr. Vasc. Pharmacol.
, vol.8
, pp. 612-631
-
-
Kostapanos, M.S.1
Liamis, G.L.2
Milionis, H.J.3
Elisaf, M.S.4
-
18
-
-
0029949970
-
Individual sulfonylureas and serious hypoglycemia in older people
-
Shorr R.I., Ray W.A., Daugherty J.R., & Griffin M.R. Individual sulfonylureas and serious hypoglycemia in older people. J. Am. Geriatr. Soc. 44, 751-755 (1996).
-
(1996)
J. Am. Geriatr. Soc.
, vol.44
, pp. 751-755
-
-
Shorr, R.I.1
Ray, W.A.2
Daugherty, J.R.3
Griffin, M.R.4
-
19
-
-
84856249507
-
Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide
-
Skoff R.A., Waterbury N.V., Shaw R.F., Egge J.A., & Cantrell M. Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide. J. Manag. Care. Pharm. 17, 664-671 (2011).
-
(2011)
J. Manag. Care. Pharm.
, vol.17
, pp. 664-671
-
-
Skoff, R.A.1
Waterbury, N.V.2
Shaw, R.F.3
Egge, J.A.4
Cantrell, M.5
-
21
-
-
0029042639
-
Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulindependent diabetes mellitus
-
Appel S., et al. Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulindependent diabetes mellitus. Am. J. Cardiol. 76, 29A-32A (1995).
-
(1995)
Am. J. Cardiol.
, vol.76
, pp. 29A-32A
-
-
Appel, S.1
-
22
-
-
84906519682
-
Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins
-
Schelleman H., et al. Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins. Br. J. Clin. Pharmacol. 78, 639-648 (2014).
-
(2014)
Br. J. Clin. Pharmacol.
, vol.78
, pp. 639-648
-
-
Schelleman, H.1
-
23
-
-
84911389837
-
Pharmacotherapy of type 2 diabetes mellitus: An update on drug-drug interactions
-
Amin M., & Suksomboon N. Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions. Drug Saf. 37, 903-919 (2014).
-
(2014)
Drug Saf.
, vol.37
, pp. 903-919
-
-
Amin, M.1
Suksomboon, N.2
-
24
-
-
0036725464
-
Interaction between free fatty acids and glucose metabolism
-
Boden G. Interaction between free fatty acids and glucose metabolism. Curr. Opin. Clin. Nutr. Metab. Care 5, 545-549 (2002).
-
(2002)
Curr. Opin. Clin. Nutr. Metab. Care
, vol.5
, pp. 545-549
-
-
Boden, G.1
-
25
-
-
0036686288
-
Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle
-
Furuhashi M., et al. Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle. J. Endocrinol. 174, 321-329 (2002).
-
(2002)
J. Endocrinol.
, vol.174
, pp. 321-329
-
-
Furuhashi, M.1
-
26
-
-
0033964873
-
Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients
-
Mussoni L., et al. Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients. Atherosclerosis 148, 397-406 (2000).
-
(2000)
Atherosclerosis
, vol.148
, pp. 397-406
-
-
Mussoni, L.1
-
27
-
-
11844254843
-
Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia
-
Damci T., Tatliagac S., Osar Z., & Ilkova H. Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia. Eur. J. Intern. Med. 14, 357-360 (2003).
-
(2003)
Eur. J. Intern. Med.
, vol.14
, pp. 357-360
-
-
Damci, T.1
Tatliagac, S.2
Osar, Z.3
Ilkova, H.4
-
28
-
-
0033998334
-
The PPARs: From orphan receptors to drug discovery
-
Willson T.M., Brown P.J., Sternbach D.D., & Henke B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43, 527-550 (2000).
-
(2000)
J. Med. Chem.
, vol.43
, pp. 527-550
-
-
Willson, T.M.1
Brown, P.J.2
Sternbach, D.D.3
Henke, B.R.4
-
29
-
-
2442660528
-
Peroxisome proliferator-Activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease
-
Tenenbaum A., et al. Peroxisome proliferator-Activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation 109, 2197-2202 (2004).
-
(2004)
Circulation
, vol.109
, pp. 2197-2202
-
-
Tenenbaum, A.1
-
30
-
-
65349134103
-
Antidiabetic action of bezafibrate in a large observational database
-
Flory J.H., Ellenberg S., Szapary P.O., Strom B.L., & Hennessy S. Antidiabetic action of bezafibrate in a large observational database. Diabetes Care 32, 547-551 (2009).
-
(2009)
Diabetes Care
, vol.32
, pp. 547-551
-
-
Flory, J.H.1
Ellenberg, S.2
Szapary, P.O.3
Strom, B.L.4
Hennessy, S.5
-
31
-
-
84879490766
-
US Government Claims Databases
-
eds. Strom B.L., Kimmel S.E., & Hennessy S.) (Wiley-Blackwell, Hoboken, NJ
-
Hennessy S., Freeman C.P., & Cunningham F. US Government Claims Databases. In Pharmacoepidemiology eds. Strom B.L., Kimmel S.E., & Hennessy S.) 209 (Wiley-Blackwell, Hoboken, NJ, 2012).
-
Pharmacoepidemiology
, vol.209
, pp. 2012
-
-
Hennessy, S.1
Freeman, C.P.2
Cunningham, F.3
-
32
-
-
0000629107
-
Medicaid databases
-
ed. Strom B.L.) (John Wiley, Sussex, UK
-
Hennessy S., Carson J.L., Ray W.A., & Strom B.L. Medicaid databases. In Pharmacoepidemiology (ed. Strom B.L.) (John Wiley, Sussex, UK 2005).
-
(2005)
Pharmacoepidemiology
-
-
Hennessy, S.1
Carson, J.L.2
Ray, W.A.3
Strom, B.L.4
-
33
-
-
36248988474
-
Quality of medicaid and medicare data obtained through centers for medicare and medicaid services cms)
-
Hennessy S., Leonard C.E., Palumbo C.M., Newcomb C., & Bilker W.B. Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS). Med. Care 45, 1216-1220 (2007).
-
(2007)
Med. Care
, vol.45
, pp. 1216-1220
-
-
Hennessy, S.1
Leonard, C.E.2
Palumbo, C.M.3
Newcomb, C.4
Bilker, W.B.5
-
34
-
-
0345356534
-
Cytochrome P450: Major player in reperfusion injury
-
Gottlieb R.A. Cytochrome P450: major player in reperfusion injury. Arch. Biochem. Biophys. 420, 262-267 (2003).
-
(2003)
Arch. Biochem. Biophys.
, vol.420
, pp. 262-267
-
-
Gottlieb, R.A.1
-
36
-
-
33644872862
-
Pravastatin improves insulin resistance in dyslipidemic patients
-
Okada K., Maeda N., Kikuchi K., Tatsukawa M., Sawayama Y., & Hayashi J. Pravastatin improves insulin resistance in dyslipidemic patients. J. Atheroscler. Thromb. 12, 322-329 (2005).
-
(2005)
J. Atheroscler. Thromb.
, vol.12
, pp. 322-329
-
-
Okada, K.1
Maeda, N.2
Kikuchi, K.3
Tatsukawa, M.4
Sawayama, Y.5
Hayashi, J.6
-
37
-
-
20444497396
-
Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients
-
Gannage-Yared M.H., et al. Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients. Metabolism 54, 947-951 (2005).
-
(2005)
Metabolism
, vol.54
, pp. 947-951
-
-
Gannage-Yared, M.H.1
-
38
-
-
47649118770
-
Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: Diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study
-
Tajima N., et al. Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study. Atherosclerosis 199, 455-462 (2008).
-
(2008)
Atherosclerosis
, vol.199
, pp. 455-462
-
-
Tajima, N.1
-
39
-
-
34548500220
-
Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease
-
Sugiyama S., et al. Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. Atherosclerosis 194, e43-51 2007).
-
(2007)
Atherosclerosis
, vol.194
, pp. e43-e51
-
-
Sugiyama, S.1
-
40
-
-
0028039904
-
Effect of pravastatin treatment on glucose, insulin, and lipoprotein metabolism in patients with hypercholesterolemia
-
Sheu W.H., et al. Effect of pravastatin treatment on glucose, insulin, and lipoprotein metabolism in patients with hypercholesterolemia. Am. Heart J. 127, 331-336 (1994).
-
(1994)
Am. Heart J.
, vol.127
, pp. 331-336
-
-
Sheu, W.H.1
-
41
-
-
67651042983
-
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data
-
Schneeweiss S., Rassen J.A., Glynn R.J., Avorn J., Mogun H., & Brookhart M.A. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology 20, 512-522 (2009).
-
(2009)
Epidemiology
, vol.20
, pp. 512-522
-
-
Schneeweiss, S.1
Rassen, J.A.2
Glynn, R.J.3
Avorn, J.4
Mogun, H.5
Brookhart, M.A.6
-
43
-
-
42449099434
-
Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits
-
Ginde A.A., Blanc P.G., Lieberman R.M., & Camargo C.A., Jr. Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits. BMC Endocr Disord. 8, 4 (2008).
-
(2008)
BMC Endocr Disord.
, vol.8
, pp. 4
-
-
Ginde, A.A.1
Blanc, P.G.2
Lieberman, R.M.3
Camargo, C.A.4
-
44
-
-
77954886592
-
Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide
-
Schelleman H., Bilker W.B., Brensinger C.M., Wan F., & Hennessy S. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide. Clin. Pharmacol. Ther. 88, 214-222 (2010).
-
(2010)
Clin. Pharmacol. Ther.
, vol.88
, pp. 214-222
-
-
Schelleman, H.1
Bilker, W.B.2
Brensinger, C.M.3
Wan, F.4
Hennessy, S.5
-
45
-
-
79958845225
-
Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples
-
Rassen J.A., Glynn R.J., Brookhart M.A., & Schneeweiss S. Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am. J. Epidemiol. 173, 1404-1413 (2011).
-
(2011)
Am. J. Epidemiol.
, vol.173
, pp. 1404-1413
-
-
Rassen, J.A.1
Glynn, R.J.2
Brookhart, M.A.3
Schneeweiss, S.4
-
46
-
-
84884469577
-
Propensity score methods for confounding control in nonexperimental research
-
Brookhart M.A., Wyss R., Layton J.B., & Sturmer T. Propensity score methods for confounding control in nonexperimental research. Circ. Cardiovasc. Qual. Outcomes 6, 604-611 (2013).
-
(2013)
Circ. Cardiovasc. Qual. Outcomes
, vol.6
, pp. 604-611
-
-
Brookhart, M.A.1
Wyss, R.2
Layton, J.B.3
Sturmer, T.4
-
47
-
-
77951622706
-
The central role of the propensity score in observational studies for causal effects
-
Rosenbaum P.R., & Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 41-55 1983).
-
(1983)
Biometrika
, pp. 41-55
-
-
Rosenbaum, P.R.1
Rubin, D.B.2
-
48
-
-
84861097401
-
Propensity score applied to survival data analysis through proportional hazards models: A Monte Carlo study
-
Gayat E., Resche-Rigon M., Mary J.Y., & Porcher R. Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study. Pharm. Stat. 11, 222-229 (2012).
-
(2012)
Pharm. Stat.
, vol.11
, pp. 222-229
-
-
Gayat, E.1
Resche-Rigon, M.2
Mary, J.Y.3
Porcher, R.4
|